Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins

被引:35
作者
Herrero-Martin, Griselda [1 ]
Lopez-Rivas, Abelardo [1 ]
机构
[1] CSIC, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain
关键词
statin; apoptosis; Bcl-2; ErbB2; mitochondria; prenylation;
D O I
10.1016/j.febslet.2008.06.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Statins are inhibitors of the mevalonate synthesis pathway that induce apoptosis in tumor cells although the apoptotic mechanism activated by statins remains to be elucidated. We have examined the role of the mitochondria- operated pathway of apoptosis in the cell death induced by statins in breast tumor cells and its regulation by protein prenylation and ErbB2 overexpression. Lovastatin treatment down- regulates the expression of Bcl- 2 and activates apoptosis through a mitochondriaoperated, ErbB2- regulated mechanism. Apoptosis induced by statins is independent of their e. ects on cholesterol synthesis and involves protein prenylation. Our results indicate that prenylation of apoptosis- regulating proteins is a key event in the survival of breast tumor cells and this requirement could be circumvented in cells overexpressing the oncogene ErbB2. (c) 2008 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:2589 / 2594
页数:6
相关论文
共 24 条
[1]   Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells [J].
Cafforio, P ;
Dammacco, F ;
Gernone, A ;
Silvestris, F .
CARCINOGENESIS, 2005, 26 (05) :883-891
[2]   Breast cancer growth prevention by statins [J].
Campbell, Michael J. ;
Esserman, Laura J. ;
Zhou, Yamei ;
Shoemaker, Mark ;
Lobo, Margaret ;
Borman, Elizabeth ;
Baehner, Frederick ;
Kumar, Anjali S. ;
Adduci, Kelly ;
Marx, Corina ;
Petricoin, Emanuel F. ;
Liotta, Lance A. ;
Winters, Mary ;
Benz, Stephen ;
Benz, Christopher C. .
CANCER RESEARCH, 2006, 66 (17) :8707-8714
[3]  
Cuello M, 2001, CANCER RES, V61, P4892
[4]   Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation [J].
Dai, Yun ;
Khanna, Payal ;
Chen, Shuang ;
Pei, Xin-Yan ;
Dent, Paul ;
Grant, Steven .
BLOOD, 2007, 109 (10) :4415-4423
[5]   Statins and cancer prevention [J].
Demierre, MF ;
Higgins, PDR ;
Gruber, SB ;
Hawk, E ;
Lippman, SM .
NATURE REVIEWS CANCER, 2005, 5 (12) :930-942
[6]   Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:: an in vitro study [J].
Denoyelle, C ;
Vasse, M ;
Körner, M ;
Mishal, Z ;
Ganné, F ;
Vannier, JP ;
Soria, J ;
Soria, C .
CARCINOGENESIS, 2001, 22 (08) :1139-1148
[7]   Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway [J].
Edwards, PA ;
Ericsson, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :157-185
[8]  
Feussner Giso, 1994, Current Opinion in Lipidology, V5, P59, DOI 10.1097/00041433-199402000-00010
[9]  
GRUNDY SM, 1988, NEW ENGL J MED, V319, P24
[10]   Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor-induced apoptosis in cancer [J].
Kaneko, Reiko ;
Tsuji, Naoki ;
Asanuma, Koichi ;
Tanabe, Hiromi ;
Kobayashi, Daisuke ;
Watanabe, Naoki .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (27) :19273-19281